Numerai’s Thermo Fisher Scientific TMO Stock Holding History

Numerai’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,615	Closed	-$3.09M	–	663
2025 Q2	$3.09M	Buy	+7,615	New	+$3.18M	0.44%	68

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Numerai's TMO Position: Q3 2025 in Review

Numerai sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 7,615 shares — an estimated $3.09M sold.

Numerai first reported a position in TMO in Q2 2025 and held it in 1 quarter. The position peaked at $3.09M in Q2 2025. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Numerai reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
Numerai sold 7,615 Thermo Fisher Scientific shares in Q3 2025, an estimated $3.09M.
Numerai first reported a position in Thermo Fisher Scientific in Q2 2025 and held it in 1 quarter.
Numerai's Thermo Fisher Scientific position peaked at $3.09M in Q2 2025.
2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Numerai's 13F filing for Q3 2025, filed 14 Nov 2025.